Clinical Research Directory
Browse clinical research sites, groups, and studies.
CERvical Cancer The InFlammatory Index (CERTIFIKO)
Sponsor: University of Campania Luigi Vanvitelli
Summary
Although significant advances in screening and treatment , cervical cancer is the fifth most common female cancer in Europe. Major prognostic factors for oncological outcome are used to categorise patients at high, intermediate and low risk groups and to define the type of radical hysterectomy according "Querleu-Morrow classification". The goal of this prospective observational study is to evaluate the association between several inflammatory markers and risk groups according European guidelines in women with cervical cancer Human Papillomavirus (HPV)-associated, in order to optimize the treatment.
Official title: CERvical Cance The InFlammatory Index as a Predictor of risK Stratification:an Observational Study
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
128
Start Date
2022-11-18
Completion Date
2024-11-18
Last Updated
2024-04-17
Healthy Volunteers
No
Conditions
Interventions
Venous blood sample
Blood chemistry tests: neutrophil;lymphocyte; monocyte; platelet counts
biopsy
histopathology findings
Locations (1)
Università degli Studi della Campania Luigi Vanvitelli
Naples, Italy